Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-09-25
Borchert et al. investigated whether defects in homologous recombination repair, including BAP1-associated changes, could identify malignant pleural mesothelioma cells susceptible to PARP inhibition. Their in vitro results support a DNA-repair-based treatment hypothesis, while the patient-sample expression analysis provides candidate markers that require clinical validation.
-
Cryo-EM Maps Full-Length αvβ3 Integrin States
2026-09-25
Cryo-EM analysis of full-length human αvβ3 integrin resolved six apo and five ligand-bound conformations, including previously uncharacterized intermediate states. The structures support a continuum model of integrin activation and show that CWHM-12 can stabilize distinct inhibited conformations, offering a structural basis for more precise inhibitor design.
-
HyperScript™ Reverse Transcriptase in M-MuLV qPCR
2026-09-24
Learn when HyperScript™ Reverse Transcriptase belongs in an M-MuLV workflow—and when it does not. This assay-design guide connects RNA-to-cDNA conversion with a published qPCR strategy that distinguishes exogenous virus from endogenous retroviral sequences.
-
Tigecycline Research in the Genomic Resistance Era
2026-09-24
Carbapenem-resistance surveillance can guide better experimental questions—but it cannot predict tigecycline susceptibility. This article connects resistance-genomics findings with a cautious, phenotype-led strategy for translational Tigecycline research.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-09-23
Learn how to interpret Annexin V/PI staining, plan flow cytometry apoptosis detection, and troubleshoot common viability-assay questions. This scenario-driven guide explains practical use and limitations of APExBIO’s Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003).
-
c-Myc tag Peptide: Assay Reliability Guide
2026-09-23
Learn how c-Myc tag Peptide (SKU A6003) can help distinguish antibody-binding effects from genuine changes in proliferation, viability, or apoptosis assays. This scenario-based guide covers reagent compatibility, stock preparation, interpretation, and practical product-selection criteria for reproducible immunoassays.
-
Protease Inhibitor Cocktail: MS-SAFE Protocol
2026-09-22
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) helps limit ex vivo protein degradation during cell and tissue extraction, including workflows prepared for mass spectrometry. Its AEBSF-free formulation is useful when MS compatibility is important, but metalloproteinases and phosphatases may require separately validated inhibitors.
-
Vorinostat Beyond Histone Acetylation
2026-09-22
Vorinostat is more than a conventional HDAC probe: it is a strategic tool for separating chromatin remodeling, transcriptional change, and mitochondrial cell death in translational oncology research.
-
Syn-LNP mRNA Vaccine Protects Guinea Pigs from Shingles
2026-09-21
Cheng and colleagues developed a synergistic lipid nanoparticle containing two ionizable lipids to deliver glycoprotein E mRNA and evaluated it as a shingles vaccine. The formulation improved mRNA expression, generated durable humoral and cellular immunity, and protected guinea pigs from live varicella zoster virus challenge, while antigen glycosylation emerged as an important design variable.
-
Carbapenemase Transmission in CREC Across Guangdong
2026-09-21
A 2025 BMC Microbiology study characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, China. Its combination of gene localization, conjugation testing, mobile-element analysis, and strain typing shows that plasmid-associated blaNDM-1 was common and highly transferable, providing a practical framework for interpreting hospital transmission risk.
-
Dinaciclib (SCH727965) for Reliable Cell Assays
2026-09-20
This scenario-driven guide shows how Dinaciclib (SCH727965), SKU A8412, can support reproducible cell-cycle, viability, and apoptosis experiments. It connects practical assay controls with the compound’s documented CDK1, CDK2, CDK5, and CDK9 activity while clarifying interpretation limits in tissue-boundary studies.
-
Carbapenemase Transmission in CREC Across Guangdong
2026-09-19
This 2025 BMC Microbiology study combined gene localization, plasmid conjugation, antimicrobial susceptibility testing, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. Its central finding is that blaNDM-1 was widely distributed across plasmids and chromosomes and transferred efficiently, highlighting the need to connect resistance genes with mobile elements, bacterial relatedness, and hospital epidemiology.
-
From Netrin-1 Biology to Better RNA Readouts
2026-09-18
The study of adipose-derived Netrin-1 illustrates how mechanistic hypotheses can be weakened by RNA-quality and reverse-transcription constraints. This thought-leadership guide connects adipose remodeling biology with assay strategy, showing where HyperScript™ Reverse Transcriptase can support more reliable translational readouts without overstating what an enzyme can prove.
-
Imidazoline Antagonists and β-Cell K+ Channels
2026-09-18
Jonas, Plant, and Henquin showed that several imidazoline α2-adrenoceptor antagonists enhance insulin release primarily by inhibiting ATP-sensitive K+ channels in pancreatic β-cells. By combining 86Rb efflux, whole-cell patch clamp, and pharmacological rescue experiments, the study separated direct ion-channel effects from receptor antagonism and established a useful framework for interpreting drug-induced insulin secretion.
-
Sulfachloropyridazine: From DHPS to Microbiome Insight
2026-09-17
Sulfachloropyridazine is more than a conventional antifolate tool. By connecting DHPS inhibition with susceptibility testing, infection biology, microbiome profiling, and metabolomics, translational researchers can use this sulfonamide antibacterial agent to distinguish direct antimicrobial activity from broader ecosystem effects.